Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 48Terminated 18Recruiting 4Withdrawn 3Active not recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Recurrence 1Neoplasm Metastasis 1Laryngeal Diseases 1Keratosis, Actinic 1Keratosis 1Head and Neck Neoplasms 1Colorectum 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Sugars × Clear all
NCT02813902 2019-03-08

A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors

Massachusetts General Hospital

Phase 1 Withdrawn
Dermatologic

Keratosis, Skin Neoplasms, Keratosis, Actinic

NCT01427205 2013-04-05

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasm Metastasis, Recurrence

NCT01550900 2013-04-05

Prospective Trial of Metformin - Chemoprevention Role

M.D. Anderson Cancer Center

Phase NA Withdrawn

Colorectum

Data powered by HemOnc (CC BY 4.0) Colophon âš¡